{
  "pmid": "35617521",
  "uid": "35617521",
  "title": "Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer.",
  "abstract": "The patient-derived organoids (PDO) platform recapitulates the phenotype, genotype, and molecular characteristics of primary tumors. High-throughput drug screening in terms of pharmacotyping using standard-of-care chemotherapy agents in the PDO platform has shown promising sensitivities to guide precision medicine for individual patients with pancreatic ductal adenocarcinoma (PDAC) within a clinically relevant time frame. See related article by Seppälä et al., p. 3296.",
  "authors": [
    {
      "last_name": "Zhang",
      "fore_name": "Yuqing",
      "initials": "Y",
      "name": "Yuqing Zhang",
      "affiliations": [
        "College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma."
      ]
    },
    {
      "last_name": "Houchen",
      "fore_name": "Courtney W",
      "initials": "CW",
      "name": "Courtney W Houchen",
      "affiliations": [
        "College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma."
      ]
    },
    {
      "last_name": "Li",
      "fore_name": "Min",
      "initials": "M",
      "name": "Min Li",
      "affiliations": [
        "College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.",
        "Department of Surgery, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma."
      ],
      "orcid": "0000-0002-3971-9130"
    }
  ],
  "journal": {
    "title": "Clinical cancer research : an official journal of the American Association for Cancer Research",
    "iso_abbreviation": "Clin Cancer Res",
    "issn": "1557-3265",
    "issn_type": "Electronic",
    "volume": "28",
    "issue": "15",
    "pub_year": "2022",
    "pub_month": "Aug",
    "pub_day": "02"
  },
  "start_page": "3176",
  "end_page": "3178",
  "pages": "3176-3178",
  "language": "eng",
  "publication_types": [
    "Editorial",
    "Research Support, Non-U.S. Gov't",
    "Research Support, N.I.H., Extramural",
    "Comment"
  ],
  "keywords": [
    "Biomarkers",
    "Carcinoma, Pancreatic Ductal",
    "Humans",
    "Organoids",
    "Pancreatic Neoplasms",
    "Precision Medicine"
  ],
  "article_ids": {
    "pubmed": "35617521",
    "mid": "NIHMS1808971",
    "pmc": "PMC9357115",
    "doi": "10.1158/1078-0432.CCR-22-1083",
    "pii": "699252"
  },
  "doi": "10.1158/1078-0432.CCR-22-1083",
  "pmc_id": "PMC9357115",
  "dates": {
    "completed": "2022-08-04",
    "revised": "2024-01-02"
  },
  "chemicals": [
    "Biomarkers"
  ],
  "grants": [
    {
      "grant_id": "R01 CA186338",
      "agency": "NCI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "R01 CA203108",
      "agency": "NCI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "R01 CA247234",
      "agency": "NCI NIH HHS",
      "country": "United States"
    }
  ],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:13:54.508979",
    "pmid": "35617521"
  }
}